Post-COVID-19 fatigue: A cross-sectional study
Abilbayeva A. Tarabayeva A. Bitanova E. Myrkassymova A. Duisenova A. Sadykova M. Sakhadin U.
2023National Scientific Medical Center
Journal of Clinical Medicine of Kazakhstan
2023#20Issue 363 - 68 pp.
Aim: To evaluate the prevalence of post-infection fatigue (PVFS) over one year after COVID-19. Material and methods: 165 people who had COVID-19 more than a year ago were interviewed. A Fatigue Assessment Scale was used to assess the degree of fatigue. Chemiluminescent analysis was carried out to detect antibodies to Epstein-Barr Virus (EBV) antigens. For statistical analysis Fishers exact test and Spearman correlation were conducted. Results: Among people with PVFS, there were 4.1 times more women than men (80.4% vs. 19.6%), people over 45 years old (76%), and people who needed hospitalization for COVID-19 (76%). The average fatigue duration was 573±18,3 days. Among individuals without PVFS, there were significantly more individuals under the age of 45 compared with the group of individuals with PVFS (40% and 24%, respectively, p=0.007) and there were significantly more individuals who did not need hospitalization compared with the group of individuals with PVFS (52% vs. 24%, p=0.005). EBV reactivation was determined in almost half of the individuals with PVFS (48%), while none of the individuals without PVFS had EBV reactivation. A statistically significant negative mean correlation was found between the duration of PVFS and the severity of PVFS (r=-0.357, p=0.007). A statistically significant negative correlation was found between the PVFS duration and the PVFS severity (r=-0.357, p=0.007). Conclusion: PVFS is a prevalent symptom after COVID-19. The duration of PVFS can reach and not be limited to 1.5 years. PVFS is more typical of women, people over 45 years of age and people who have had moderate and severe COVID-19. Over time, the severity of PVFS decreases.
COVID-19 , Epstein-Barr virus , post-infection fatigue
Text of the article Перейти на текст статьи
Department of General Immunology, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
Department of Biostatistics and Basics of Scientific Research, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
Department of Infectious and tropical diseases, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
Department of General Immunology
Department of Biostatistics and Basics of Scientific Research
Department of Infectious and tropical diseases
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026